Hester Biosciences [HESTERBIO] vs Themis Medicare [THEMISMED] Detailed Stock Comparison

Hester Biosciences Ltd.

NSE
Loading...

Themis Medicare Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Hester Biosciences Ltd. wins in 13 metrics, Themis Medicare Ltd. wins in 7 metrics, with 0 ties. Hester Biosciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Hester Biosciences Ltd. Themis Medicare Ltd. Better
P/E Ratio (TTM) 30.37 32.38 Hester Biosciences Ltd.
Price-to-Book Ratio 3.73 2.22 Themis Medicare Ltd.
Debt-to-Equity Ratio 60.85 25.15 Themis Medicare Ltd.
PEG Ratio -1.65 0.02 Themis Medicare Ltd.
EV/EBITDA 19.66 -81.74 Hester Biosciences Ltd.
Profit Margin (TTM) 12.97% -5.16% Hester Biosciences Ltd.
Operating Margin (TTM) 17.26% 7.99% Hester Biosciences Ltd.
EBITDA Margin (TTM) 17.26% 7.99% Hester Biosciences Ltd.
Return on Equity 8.41% 7.41% Hester Biosciences Ltd.
Return on Assets (TTM) 4.21% 5.07% Themis Medicare Ltd.
Free Cash Flow (TTM) $439.20M $192.84M Hester Biosciences Ltd.
Dividend Yield 0.64% 0.50% Hester Biosciences Ltd.
1-Year Return 5.05% -24.55% Hester Biosciences Ltd.
Price-to-Sales Ratio (TTM) 3.96 2.50 Themis Medicare Ltd.
Enterprise Value $14.12B $9.17B Hester Biosciences Ltd.
EV/Revenue Ratio 4.47 2.72 Themis Medicare Ltd.
Gross Profit Margin (TTM) 73.22% 67.63% Hester Biosciences Ltd.
Revenue per Share (TTM) $369 $37 Hester Biosciences Ltd.
Earnings per Share (Diluted) $48.41 $-1.89 Hester Biosciences Ltd.
Beta (Stock Volatility) 0.22 0.06 Themis Medicare Ltd.

Hester Biosciences Ltd. vs Themis Medicare Ltd. Stock Performance Analysis

Loading Price Chart...

HESTERBIO
THEMISMED

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hester Biosciences Ltd.5.82%5.27%12.84%43.52%29.64%29.64%
Themis Medicare Ltd.-1.04%-0.73%5.41%35.48%-1.86%3.09%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hester Biosciences Ltd.5.05%19.30%-22.79%198.65%322.75%322.75%
Themis Medicare Ltd.-24.55%-27.27%45.69%88.42%535.25%703.01%

Performance & Financial Health Analysis: Hester Biosciences Ltd. vs Themis Medicare Ltd.

MetricHESTERBIOTHEMISMED
Market Information
Market Cap i₹12.57B₹8.57B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i3,34175,711
90 Day Avg. Volume i4,944127,228
Last Close₹2,066.60₹102.91
52 Week Range₹1,239.30 - ₹2,350.00₹64.95 - ₹148.00
% from 52W High-12.06%-30.47%
All-Time High₹3,379.00 (Jul 22, 2024)₹1,834.00 (Sep 25, 2023)
% from All-Time High-38.84%-94.39%
Growth Metrics
Quarterly Revenue Growth0.09%-0.04%
Quarterly Earnings Growth-0.25%18.44%
Financial Health
Profit Margin (TTM) i0.13%-0.05%
Operating Margin (TTM) i0.17%0.08%
Return on Equity (TTM) i0.08%0.07%
Debt to Equity (MRQ) i60.8525.15
Cash & Liquidity
Book Value per Share (MRQ)₹394.06₹40.99
Cash per Share (MRQ)₹9.91₹1.39
Operating Cash Flow (TTM) i₹554.94M₹382.22M
Levered Free Cash Flow (TTM) i₹274.88M₹298.33M
Dividends
Last 12-Month Dividend Yield i0.64%0.50%
Last 12-Month Dividend i₹13.00₹0.50

Valuation & Enterprise Metrics Analysis: Hester Biosciences Ltd. vs Themis Medicare Ltd.

MetricHESTERBIO (Apr 24, 2026)THEMISMED (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i30.3732.38
Forward P/E iN/AN/A
PEG Ratio i-1.650.02
Price to Sales (TTM) i3.962.50
Price to Book (MRQ) i3.732.22
Market Capitalization
Market Capitalization i₹12.57B₹8.57B
Enterprise Value i₹14.12B₹9.17B
Enterprise Value Metrics
Enterprise to Revenue i4.472.72
Enterprise to EBITDA i19.66-81.74
Risk & Other Metrics
Beta i0.220.06
Book Value per Share (MRQ) i₹394.06₹40.99

Financial Statements Comparison: Hester Biosciences Ltd. vs Themis Medicare Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHESTERBIO (2025)THEMISMED (2025)
Revenue/Sales i3.11B4.00B
Cost of Goods Sold i1.03B1.34B
COGS % of Revenue i33.0%33.5%
Gross Profit i2.08B2.66B
Gross Margin i67.0%66.5%
Research & Development iN/AN/A
Operating Income (EBIT) i452.43M391.53M
Operating Margin i14.5%9.8%
EBITDA i651.99M581.30M
EBITDA Margin i21.0%14.5%
Pre-Tax Income i395.71M396.75M
Pre-Tax Income % of Revenue i12.7%9.9%
Income Tax i107.45M98.42M
Income Tax % of Revenue i3.5%2.5%
Net Income (Profit) i288.26M298.33M
Profit Margin i9.3%7.5%

Balance Sheet & Liquidity Metrics

MetricHESTERBIO (2025)THEMISMED (2025)
Cash & Equivalents i55.87M65.59M
Total Current Assets i1.95B3.04B
Total Current Assets % of Revenue i62.7%76.0%
Total Current Liabilities i1.25B1.56B
Total Current Liabilities % of Revenue i40.2%39.0%
Long-Term Debt i1.39B186.12M
Long-Term Debt % of Revenue i44.6%4.7%
Total Shareholders Equity i3.27B4.03B
Retained Earnings i2.37B2.57B
Retained Earnings % of Revenue i76.2%64.3%
Property, Plant & Equipment i59.22M56.40M

Cash Flow Statement Comparison

MetricHESTERBIO (2025)THEMISMED (2025)
Operating Cash Flow i554.94M382.22M
Operating Cash Flow % of Revenue i17.8%9.6%
Capital Expenditures i2.74M-137.44M
Free Cash Flow i439.20M192.84M
FCF Margin i14.1%4.8%
Debt Repayment i-331.16MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricHESTERBIOTHEMISMED
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i8.51M92.10M
Float Shares i2.50M23.48M
% Held by Insiders i68.79%74.89%
% Held by Institutions i0.37%0.05%
% Held by Public i30.84%25.06%

Dividend Analysis & Yield Comparison: Hester Biosciences Ltd. vs Themis Medicare Ltd.

MetricHESTERBIOTHEMISMED
Last 12-Month Dividend i₹13.00₹0.50
Last 12-Month Dividend Yield i0.64%0.50%
3-Year Avg Annual Dividend i₹10.33₹0.37
3-Year Avg Dividend Yield i0.37%0.18%
3-Year Total Dividends i₹31.00₹1.10
Ex-Dividend DateAug 06, 2025Sep 04, 2025